Abacus Diagnostica Overview
- Founded
- 2004
- Status
- Private
- Employees
- 30
- Latest Deal Type
- Angel
- Latest Deal Amount
- $2.43M
- Investors
- 2
Abacus Diagnostica General Information
Description
Developer of rapid molecular diagnostic test system designed to make disease testing in healthcare easy, fast and cost-effective. The company's test system consists of single-use disposable test chips, a measuring device and software to interpret the test results, enabling healthcare providers with reliable molecular diagnostics that can also be used in resource and capability-limited settings.
Contact Information
Website
www.abacusdiagnostica.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
- ElectroCity
- Tykistökatu 4 D, 2nd floor
- 20520 Turku
- Finland
+358 020 0000000
Abacus Diagnostica Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 15-Jul-2020 | $2.43M | 00.000 | 00.000 | Completed | Generating Revenue/Not Profitable |
| 2. Angel (individual) | 16-Jun-2014 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 1. Later Stage VC (Series A) | 16-May-2013 | $5.48M | $5.48M | 000.00 | Completed | Generating Revenue |
Abacus Diagnostica Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 00,000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | ||
| Ordinary | 00,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Ordinary | 2,500 | $112.62 | $112.62 | 1x | $112.62 | 4.54% | ||
| Series A | 3,000 | $1576.66 | $1576.66 | 1x | $1576.66 | 5.45% |
Abacus Diagnostica Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of rapid molecular diagnostic test system designed to make disease testing in healthcare easy, fast and cost-e
Diagnostic Equipment
Turku, Finland
30
As of 2021
00.000
0.000
0000-00-00
0000000000
00.000
0000 000
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repre
0000000000 000000000
San Diego, CA
000
As of 0000
0000
0000
0000-00-00
000000&0
0000
0000000
iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commo
0000000000 000000000
Québec, Canada
000
As of 0000
0000
0000-00-00
000000&0
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAbacus Diagnostica Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mesa Biotech | Formerly VC-backed | San Diego, CA | 000 | 0000 | 000000&0 | 0000 |
| 0000000 | Corporate Backed or Acquired | Québec, Canada | 000 | 000000&0 | ||
| 0000 00000 0000000 | Corporation | Rockville, MD | 0000000000 | |||
| 00 00000000 000000 | Corporate Backed or Acquired | Bhopal, India | 00000000000 | |||
| 0000000 | Formerly VC-backed | Sunnyvale, CA | 0000 | 000.00 | 000000&0 | 000.00 |
Abacus Diagnostica Patents
Abacus Diagnostica Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2430187-A2 | Method for detecting nucleic acids | Withdrawn | 12-May-2009 | 0000000000 | 0 |
| US-20120040349-A1 | Method for detecting nucleic acids | Abandoned | 12-May-2009 | 0000000000 | 0 |
| US-20140017689-A1 | Method for detecting nucleic acids | Abandoned | 12-May-2009 | 0000000000 | 0 |
| US-8247171-B2 | Method for detection of presence of target polynucleotide in samples | Active | 09-Mar-2007 | 0000000000 | 0 |
| US-20100081139-A1 | Method for detection of presence of target polynucleotide in samples | Granted | 01-Feb-2007 | C12Q1/6818 | 0 |
Abacus Diagnostica Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Erno Sundberg | Chief Executive Officer |
Abacus Diagnostica Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ilkka Kouvonen Ph.D | Self | Board Member | 000 0000 |
| Leena Kokko | Abacus Diagnostica | Board Member | 000 0000 |
| Tero Soukka | Abacus Diagnostica | Board Member | 000 0000 |
| Timo Lövgren | Abacus Diagnostica | Board Member | 000 0000 |
Abacus Diagnostica Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAbacus Diagnostica Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Finnvera | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Innovestor | Venture Capital | Minority | 000 0000 | 000000 0 |